Stigma and Nihilism Task Group

Task Group Charge:

To address the broad challenges related to the influence that stigma and nihilism have persons living with and at risk for the development of lung cancer related to quality of life, cancer care, and prognosis

Leadership

Image for Lisa Carter-Bawa, PhD, APRN, ANP-C, FAAN
Lisa Carter-Bawa, PhD, APRN, ANP-C, FAAN

Task Group Chair Director

Cancer Prevention Precision Control Institute Center for Discovery & Innovation at Hackensack Meridian Health
Image for Jamie L. Studts, PhD
Jamie L. Studts, PhD

Steering Committee Member

Task Group Members

Nancy Alvey
Survivor and Lung Cancer Advocate
Kentucky LEADS Collaborative

Abbie Begnaud, MD
University of Minnesota

Dannell D. Boatman, EdD, MS
West Virginia University

Deborah Brown
American Lung Association

Andrew Chang, MD
University of Michigan

Deena Cook
Survivor and Lung Cancer Advocate
GO2 for Lung Cancer

Dusty Donaldson, MA
Survivor and Lung Cancer Advocate
Dusty Joy Foundation (LiveLung)

Jill Feldman*
Patient Advocate
EGFR Resisters

Heidi Hamann, PhD
University of Arizona

Eugene Manley, Jr., PhD
LUNGevity Foundation

Drew Moghanaki, MD, MPH
UCLA Health

(*) indicates Steering Committee member

Jamie Ostroff, PhD*
Memorial Sloan Kettering Cancer Center

James Pantelas
Survivor and Lung Cancer Advocate
GO2 Foundation for Lung Cancer

Elyse Park, PhD, MPH
Massachusetts General Hospital

Maureen Rigney, LISCW
GO2 Foundation for Lung Cancer

Elizabeth Rohan, PhD, MSW
Centers for Disease Control and Prevention

Pamela Samson, MD, MPHS
Washington University School of Medicine in St. Louis

Elizabeth Scharnetzki, PhD
MaineHealth Institute for Research

Joan Schiller, MD
Lung Cancer Research Foundation

Cardinale Smith, MD, PhD
Mount Sinai Health System

Brendon Stiles, MD, FACS
Montefiore-Einstein Cancer Center

Anne Stangl, PhD, MPH
Centers for Disease Control

Erica T. Warner, ScD, MPH
Massachusetts General Hospital

Timothy Williamson, PhD, MPH
Loyola Marymount University

Opportunities For Intervention/Influence:

  • Address stigma across the lung cancer control continuum with the goal of eliminating stigma as an obstacle to quality of life, care delivery, and health outcomes
  • Identify and address the causes and impact of nihilism regarding lung cancer risk reduction, screening, diagnosis and treatment

Eliminating Lung Cancer Stigma: A National Initiative

Campaign to End Lung Cancer Stigma

Resources